QUARTERLY FOCUS ISSUE: HEART FAILURE: CLINICAL RESEARCH
Familial Dilated Cardiomyopathy Caused by an Alpha-Tropomyosin MutationThe Distinctive Natural History of Sarcomeric Dilated Cardiomyopathy
Neal K. Lakdawala, MD*,
Lisa Dellefave, MS, CGC ,
Charles S. Redwood, PhD ,
Elizabeth Sparks, RNP ,
Allison L. Cirino, MS, CGC*,
Steve Depalma, PhD ,
Steven D. Colan, MD||,
Birgit Funke, PhD¶,
Rebekah S. Zimmerman, PhD¶,
Paul Robinson, DPhil ,
Hugh Watkins, MD, PhD ,
Christine E. Seidman, MD*, ,#,
J.G. Seidman, PhD ,
Elizabeth M. McNally, MD, PhD and
Carolyn Y. Ho, MD*,*
* Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts
Department of Medicine, Section of Cardiology, The University of Chicago, Chicago, Illinois
University of Oxford, Oxford, United Kingdom
Department of Genetics, Harvard Medical School, Boston, Massachusetts
|| Department of Cardiology, Children's Hospital Boston, Boston, Massachusetts
¶ Harvard Medical School–Partners Healthcare Center for Personalized Genetic Medicine, Cambridge, Massachusetts
# Howard Hughes Medical Institute, Cambridge, Massachusetts
Manuscript received August 7, 2009;
revised manuscript received October 21, 2009,
accepted November 9, 2009.
* Reprint requests and correspondence: Dr. Carolyn Y. Ho, Brigham and Women's Hospital, 75 Francis Street, Boston, Massachusetts 02115 (Email: cho{at}partners.org).
Objectives: We sought to further define the role of sarcomere mutations in dilated cardiomyopathy (DCM) and associated clinical phenotypes.
Background: Mutations in several contractile proteins contribute to DCM, but definitive evidence for the roles of most sarcomere genes remains limited by the lack of robust genetic support.
Methods: Direct sequencing of 6 sarcomere genes was performed on 334 probands with DCM. A novel D230N missense mutation in the gene encoding alpha-tropomyosin (TPM1) was identified. Functional assessment was performed by the use of an in vitro reconstituted sarcomere complex to evaluate ATPase regulation and Ca2+ affinity as correlates of contractility.
Results: TPM1 D230N segregated with DCM in 2 large unrelated families. This mutation altered an evolutionarily conserved residue and was absent in >1,000 control chromosomes. In vitro studies demonstrated major inhibitory effects on sarcomere function with reduced Ca2+ sensitivity, maximum activation, and Ca2+ affinity compared with wild-type TPM1. Clinical manifestations ranged from decompensated heart failure or sudden death in those presenting early in life to asymptomatic left ventricular dysfunction in those diagnosed during adulthood. Notably, several affected infants had remarkable improvement.
Conclusions: Genetic segregation in 2 unrelated families and functional analyses conclusively establish a pathogenic role for TPM1 mutations in DCM. In vitro results demonstrate contrasting effects of DCM and hypertrophic cardiomyopathy mutations in TPM1, suggesting that specific functional consequences shape cardiac remodeling. Along with previous reports, our data support a distinctive, age-dependent phenotype with sarcomere-associated DCM where presentation early in life is associated with severe, sometimes lethal, disease. These observations have implications for the management of familial DCM.
Key Words: cardiomyopathy heart failure genetics
|
Abbreviations and Acronyms
| | DCM = dilated cardiomyopathy | | HCM = hypertrophic cardiomyopathy | | HF = heart failure | | LV = left ventricular/ventricle | | LVIDD = left ventricular end-diastolic internal diameter | | LVEF = left ventricular ejection fraction |
|
Related Articles
-
Tropomyosin and Dilated Cardiomyopathy: Revenge of the Actinomyosin "Gatekeeper"
- Jil C. Tardiff
J. Am. Coll. Cardiol. 2010 55: 330-332.
[Full Text]
[PDF]
-
Inside This Issue
J. Am. Coll. Cardiol. 2010 55: A35-A33.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
D. Jacoby and W. J. McKenna
Genetics of inherited cardiomyopathy
Eur. Heart J.,
February 1, 2012;
33(3):
296 - 304.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Wang, W. Li, G.-Q. Chang, C.-S. Ye, J.-S. Ou, X.-X. Li, Y. Liu, T.-Y. Cheang, X.-L. Huang, and S.-M. Wang
MicroRNA-21 Regulates Vascular Smooth Muscle Cell Function via Targeting Tropomyosin 1 in Arteriosclerosis Obliterans of Lower Extremities
Arterioscler Thromb Vasc Biol,
September 1, 2011;
31(9):
2044 - 2053.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Bloemink, G. C. Melkani, C. M. Dambacher, S. I. Bernstein, and M. A. Geeves
Two Drosophila Myosin Transducer Mutants with Distinct Cardiomyopathies Have Divergent ADP and Actin Affinities
J. Biol. Chem.,
August 12, 2011;
286(32):
28435 - 28443.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. E. Hershberger and J. D. Siegfried
Update 2011: Clinical and Genetic Issues in Familial Dilated Cardiomyopathy
J. Am. Coll. Cardiol.,
April 19, 2011;
57(16):
1641 - 1649.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. T. Owens and M. Jessup
The Year in Heart Failure
J. Am. Coll. Cardiol.,
April 12, 2011;
57(15):
1573 - 1583.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Tardiff
Thin Filament Mutations: Developing an Integrative Approach to a Complex Disorder
Circ. Res.,
March 18, 2011;
108(6):
765 - 782.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. DeMaria, J. J. Bax, O. Ben-Yehuda, G. K. Feld, B. H. Greenberg, J. Hall, M. Hlatky, W. Y. W. Lew, J. A. C. Lima, A. S. Maisel, et al.
Highlights of the Year in JACC 2010
J. Am. Coll. Cardiol.,
January 25, 2011;
57(4):
480 - 514.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Rasi, J. Piuhola, M. Czabanka, R. Sormunen, M. Ilves, H. Leskinen, J. Rysa, R. Kerkela, P. Janmey, R. Heljasvaara, et al.
Collagen XV Is Necessary for Modeling of the Extracellular Matrix and Its Deficiency Predisposes to Cardiomyopathy
Circ. Res.,
November 12, 2010;
107(10):
1241 - 1252.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Tardiff
Tropomyosin and Dilated Cardiomyopathy: Revenge of the Actinomyosin "Gatekeeper"
J. Am. Coll. Cardiol.,
January 26, 2010;
55(4):
330 - 332.
[Full Text]
[PDF]
|
 |
|
|